Strong Industry Position Success TMS is the second largest provider of TMS therapy worldwide with a substantial revenue reach of up to 50 million dollars, indicating robust market presence and a proven track record in the neurohealth treatment space.

Innovative Partnerships The company's exclusive use of Neuronetics’ NeuroStar Advanced Therapy platform highlights a strategic partnership that showcases its commitment to cutting-edge technology, presenting opportunities to cross-sell or integrate complementary neurohealth solutions.

Expanding Leadership Recent addition of a veteran healthcare executive as COO signals a focus on operational excellence and growth acceleration, suggesting potential for scaling services and exploring new markets or regions.

Growing Revenue With revenue between 25 and 50 million dollars, Success TMS demonstrates solid financial health and a demand-driven market, making it attractive for suppliers of medical technology, consumables, and support services for TMS treatments.

Market Demand The focus on med-free, FDA-approved treatments for depression that are insurance-covered indicates a strong and expanding market segment, presenting opportunities for sales of related medical devices, tech solutions, and patient support programs.